These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1822086)

  • 1. Serum sickness-like illness and leukocytoclastic vasculitis after intravenous streptokinase.
    Patel A; Prussick R; Buchanan WW; Sauder DN
    J Am Acad Dermatol; 1991 Apr; 24(4):652-3. PubMed ID: 1822086
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum-sickness-like illness as a complication after streptokinase therapy for acute myocardial infarction.
    Schweitzer DH; van der Wall EE; Bosker HA; Scheffer E; Macfarlane JD
    Cardiology; 1991; 78(1):68-71. PubMed ID: 2021968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous leukocytoclastic vasculitis in relation to streptokinase.
    Bindels AJ; See TL; Peters WG
    Neth J Med; 1992 Feb; 40(1-2):76-9. PubMed ID: 1579189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum sickness-like illness and leukocytoclastic vasculitis following intracoronary arterial streptokinase.
    Noel J; Rosenbaum LH; Gangadharan V; Stewart J; Galens G
    Am Heart J; 1987 Feb; 113(2 Pt 1):395-7. PubMed ID: 3812196
    [No Abstract]   [Full Text] [Related]  

  • 5. Manifestations of drug reactions. Urticaria and cutaneous necrotizing venulitis.
    Gammon WR
    Clin Dermatol; 1986; 4(1):50-7. PubMed ID: 3270403
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypersensitivity vasculitis complicating intravenous streptokinase therapy in acute myocardial infarction.
    Ong AC; Handler CE; Walker JM
    Int J Cardiol; 1988 Oct; 21(1):71-3. PubMed ID: 3220603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum sickness-like illness following streptokinase therapy. A case report.
    Creamer JD; McGrath JA; Webb-Peploe M; Smith NP
    Clin Exp Dermatol; 1995 Nov; 20(6):468-70. PubMed ID: 8857338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sickness and purpura following intravenous streptokinase.
    Clesham GJ; Terry HJ; Jalihal S; Toghill PJ
    J R Soc Med; 1992 Oct; 85(10):638-9. PubMed ID: 1433049
    [No Abstract]   [Full Text] [Related]  

  • 9. Quinidine-induced vasculitis.
    Shalit M; Flugelman MY; Harats N; Galun E; Ackerman Z; Kopolovic J; Eliakim M
    Arch Intern Med; 1985 Nov; 145(11):2051-2. PubMed ID: 4062457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasculitis complicating treatment with intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Bucknall C; Darley C; Flax J; Vincent R; Chamberlain D
    Br Heart J; 1988 Jan; 59(1):9-11. PubMed ID: 2963655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute renal failure following intravenous streptokinase infusion for acute myocardial infarction.
    Birnbaum Y; Strasberg B; Rechavia E; Neuman Y; Stahl B
    West J Med; 1993 Apr; 158(4):406-9. PubMed ID: 8317134
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphocytic angiitis following streptokinase therapy.
    Sorber WA; Herbst V
    Cutis; 1988 Jul; 42(1):57-8. PubMed ID: 3060319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teicoplanin-induced purpuric eruption with leukocytoclastic vasculitis.
    Uchida Y; Higashi Y; Kanekura T
    Eur J Dermatol; 2014; 24(6):689-90. PubMed ID: 25179378
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypersensitivity vasculitis associated with streptokinase.
    Thompson RF; Stratton MA; Heffron WA
    Clin Pharm; 1985; 4(4):383, 386. PubMed ID: 2931234
    [No Abstract]   [Full Text] [Related]  

  • 15. Painful purpura on bilateral helices.
    Mahmood T; Delacerda A; Fiala K
    JAMA Dermatol; 2015 May; 151(5):551-2. PubMed ID: 25549349
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum sickness from iron-dextran administration.
    Bielory L
    Acta Haematol; 1990; 83(3):166-8. PubMed ID: 2109460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum sickness following streptokinase therapy.
    Totty WG; Romano T; Benian GM; Gilula LA; Sherman LA
    AJR Am J Roentgenol; 1982 Jan; 138(1):143-4. PubMed ID: 6976690
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypersensitivity vasculitis after thrombolytic therapy with APSAC (anisoylated plasminogen streptokinase activator complex). Presentation of a clinical case and review of the literature].
    Gianni R; Benucci M; Santoro E; Nenci G; Baruffi MC; Cappelletti C
    Ann Ital Med Int; 1994; 9(2):105-6. PubMed ID: 7917762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypersensitivity vasculitis associated with streptokinase.
    Manoharan A; Ramsay D; Davis S; Lvoff R
    Aust N Z J Med; 1986 Dec; 16(6):815-6. PubMed ID: 3471202
    [No Abstract]   [Full Text] [Related]  

  • 20. Leukocytoclastic vasculitis with purpura and renal failure induced by the anti-epidermal growth factor receptor antibody panitumumab: a case report.
    Kamo H; Shinozaki E; Sugase T; Mizunuma N; Taniguchi S; Gotoh T; Chin K; Tanaka T; Koga K; Yamaguchi K
    J Med Case Rep; 2019 Jan; 13(1):13. PubMed ID: 30646927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.